What is the appropriate dosage of Zofran (ondansetron) for a 15-month-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron Dosing for a 15-Month-Old Child

For a 15-month-old child, ondansetron should be dosed at 0.15 mg/kg per dose (maximum 16 mg), administered orally, intravenously, or intramuscularly depending on the clinical scenario. 1

Weight-Based Dosing Calculation

  • A typical 15-month-old weighs approximately 10-12 kg 1
  • Using the standard pediatric dose of 0.15 mg/kg:
    • For a 10 kg child: 1.5 mg per dose
    • For a 12 kg child: 1.8 mg per dose 1
  • The maximum single dose is 16 mg, though this ceiling is rarely relevant for toddlers 1

Route of Administration by Clinical Context

For Acute Gastroenteritis (Most Common Indication)

  • Oral disintegrating tablet (ODT) is preferred for ease of administration in young children 2, 3
  • Single dose of 0.15 mg/kg orally in the emergency department or clinic setting 3
  • Onset of action occurs within 30 minutes of oral administration 4

For Food Protein-Induced Enterocolitis Syndrome (FPIES)

  • Ondansetron is appropriate for children ≥6 months of age 5, 1
  • For mild episodes: 0.15 mg/kg intramuscularly (maximum 16 mg) 5, 1
  • For moderate-to-severe episodes: 0.15 mg/kg intravenously or intramuscularly (maximum 16 mg) 5, 1
  • This 15-month-old meets the age requirement for safe use 5

For Chemotherapy-Induced Nausea/Vomiting

  • 0.15 mg/kg IV 30 minutes before chemotherapy, then repeat at 4 and 8 hours after the first dose 1, 2
  • Combining with dexamethasone significantly improves efficacy 1, 2

Critical Safety Considerations

Age-Specific Precautions

  • Do not use in infants under 6 months of age for FPIES management due to limited safety data 5, 1
  • At 15 months, this child is well above the minimum age threshold 5

QT Interval Prolongation

  • Ondansetron can prolong the QT interval in a dose-dependent manner 1, 6
  • The 0.15 mg/kg dose with 16 mg maximum provides an appropriate safety margin 1
  • Use with special caution in children with underlying heart disease 5

Overdose Risk in Toddlers

  • Severe toxicity has been reported in a 12-month-old who ingested 56-64 mg (seven to eight 8 mg tablets), resulting in seizures, obtundation, and serotonin syndrome 6
  • Counsel caregivers to store ondansetron securely out of reach of toddlers, particularly the ODT formulation which may be mistaken for candy 6

Pharmacokinetic Considerations in Young Children

  • Pediatric patients have increased clearance compared to adults, with a shorter half-life of approximately 2.5-3 hours 4, 7
  • This faster metabolism supports the safety of standard weight-based dosing in toddlers 4
  • Peak plasma concentrations occur 1 hour after oral administration 4

Common Pitfalls to Avoid

  • Avoid repeat dosing within 4 hours unless specifically indicated for chemotherapy protocols 1
  • Do not exceed the maximum single dose of 16 mg, even in larger toddlers 1
  • Do not use routinely for simple viral gastroenteritis without evidence of dehydration or failed oral rehydration 3
  • Recognize that ondansetron does not treat the underlying cause and should be part of comprehensive rehydration therapy 3

Expected Efficacy and Monitoring

  • In gastroenteritis, ondansetron reduces vomiting episodes and improves oral rehydration success 2, 3
  • Monitor for ongoing vomiting, adequate oral intake, and signs of dehydration after administration 3
  • The dose range of 0.13-0.26 mg/kg shows similar efficacy, so precise weight-based calculation is less critical than ensuring the dose falls within this range 3

Tolerability Profile

  • Generally well tolerated in young children 2, 7
  • Most common adverse effects include headache (less relevant in toddlers who cannot report it), constipation, and diarrhea 2, 7
  • Ondansetron does not cause extrapyramidal reactions, unlike metoclopramide, making it safer for pediatric use 7

References

Guideline

Ondansetron Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ondansetron: a novel antiemetic agent.

Southern medical journal, 1993

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Obtundation and seizure following ondansetron overdose in an infant.

Clinical toxicology (Philadelphia, Pa.), 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.